Politician
Josh Gottheimer
DemocratHouseNJ
Trades
1,395
Issuers
290
Volume
230.55M
Related Reading
- 10 days ago
Apple's Strategic EV Turn and the Political Stock Narrative
- 2024-02-14
U.S Senate Approves $95B Wartime Aid Package For Israel & Ukraine
- 2024-02-14
Moderna Stock Tumbles As RSV Vaccine Faces Efficiency Concerns
- 2024-01-30
Congressman Gains From Oracle Stock As Company Moves Into AI
- 2024-01-22
How Is the Gaza Conflict Weighing on Us Congressional Trading?
ChemoCentryx would later be acquired by Amgen, netting Gottheimer a return of over 140% on his trade.